Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clarithromycin Immunomodulation in Influenza
NCT03824847Phase 4Suspended
- Sponsor
- The University of Hong Kong
- Start
- Jun 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clarithromycin in influenza, sponsored by The University of Hong Kong. Started Jun 2023; status: suspended.
02
Drugs
clarithromycin
03
Conditions
influenza
Beyond the preview
Go deeper on NCT03824847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03824847.